Madam Speaker, as Canada emerges out of the acute phase of the pandemic, the focus will shift toward ongoing management of COVID-19. Individual public health measures, along with vaccines and therapeutics, will remain key in protecting individuals should a virulent and highly transmissible variant of concern emerge. The Public Health Agency of Canada is working with its provincial and territorial partners to address the ongoing presence of the COVID-19 virus. Given the uncertainty, nimble approaches will continue to be required as measures are lifted.
In the House of Commons on June 1st, 2022. See this statement in context.